Medical - Care Facilities
Compare Stocks
4 / 10Stock Comparison
AMN vs UNH vs HCSG vs HCA
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Care Facilities
Medical - Care Facilities
AMN vs UNH vs HCSG vs HCA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Healthcare Plans | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $869M | $335.60B | $1.60B | $95.95B |
| Revenue (TTM) | $3.42B | $449.71B | $1.84B | $75.60B |
| Net Income (TTM) | $-32M | $12.04B | $59M | $6.78B |
| Gross Margin | 25.5% | 18.8% | 13.3% | 41.5% |
| Operating Margin | 0.3% | 4.2% | 3.0% | 15.8% |
| Forward P/E | 11.0x | 20.2x | 20.8x | 14.2x |
| Total Debt | $803M | $78.39B | $25M | $50.20B |
| Cash & Equiv. | $34M | $24.36B | $161M | $1.04B |
AMN vs UNH vs HCSG vs HCA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AMN Healthcare Serv… (AMN) | 100 | 50.7 | -49.3% |
| UnitedHealth Group … (UNH) | 100 | 121.3 | +21.3% |
| Healthcare Services… (HCSG) | 100 | 93.3 | -6.7% |
| HCA Healthcare, Inc. (HCA) | 100 | 401.5 | +301.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMN vs UNH vs HCSG vs HCA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMN is the clearest fit if your priority is value.
- Lower P/E (11.0x vs 14.2x)
UNH is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 25 yrs, beta 0.59, yield 2.4%
- Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
- 11.8% revenue growth vs AMN's -8.5%
- 2.4% yield, 25-year raise streak, vs HCA's 0.7%, (2 stocks pay no dividend)
HCSG is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.12, Low D/E 4.8%, current ratio 3.38x
- +55.8% vs UNH's -3.2%
HCA carries the broadest edge in this set and is the clearest fit for long-term compounding and defensive.
- 450.5% 10Y total return vs UNH's 220.6%
- Beta 0.29, yield 0.7%, current ratio 0.83x
- 9.0% margin vs AMN's -0.9%
- Beta 0.29 vs HCSG's 1.12
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.8% revenue growth vs AMN's -8.5% | |
| Value | Lower P/E (11.0x vs 14.2x) | |
| Quality / Margins | 9.0% margin vs AMN's -0.9% | |
| Stability / Safety | Beta 0.29 vs HCSG's 1.12 | |
| Dividends | 2.4% yield, 25-year raise streak, vs HCA's 0.7%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +55.8% vs UNH's -3.2% | |
| Efficiency (ROA) | 11.3% ROA vs AMN's -1.4%, ROIC 19.9% vs 1.6% |
AMN vs UNH vs HCSG vs HCA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AMN vs UNH vs HCSG vs HCA — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMN leads in 1 of 6 categories
HCSG leads 1 • HCA leads 1 • UNH leads 1 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — AMN and HCA each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 244.8x HCSG's $1.8B. HCA is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to AMN's -0.9%. On growth, AMN holds the edge at +99.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $3.4B | $449.7B | $1.8B | $75.6B |
| EBITDAEarnings before interest/tax | $127M | $23.2B | $72M | $15.5B |
| Net IncomeAfter-tax profit | -$32M | $12.0B | $59M | $6.8B |
| Free Cash FlowCash after capex | $714M | $19.7B | $139M | $7.7B |
| Gross MarginGross profit ÷ Revenue | +25.5% | +18.8% | +13.3% | +41.5% |
| Operating MarginEBIT ÷ Revenue | +0.3% | +4.2% | +3.0% | +15.8% |
| Net MarginNet income ÷ Revenue | -0.9% | +2.7% | +3.2% | +9.0% |
| FCF MarginFCF ÷ Revenue | +20.9% | +4.4% | +7.6% | +10.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +99.9% | +2.0% | +6.6% | +6.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.8% | +0.7% | +175.0% | +44.6% |
Valuation Metrics
AMN leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 15.1x trailing earnings, HCA trades at a 46% valuation discount to UNH's 27.9x P/E. On an enterprise value basis, AMN's 8.6x EV/EBITDA is more attractive than HCSG's 22.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $869M | $335.6B | $1.6B | $95.9B |
| Enterprise ValueMkt cap + debt − cash | $1.6B | $389.6B | $1.5B | $145.1B |
| Trailing P/EPrice ÷ TTM EPS | -9.06x | 27.95x | 27.54x | 15.12x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.05x | 20.19x | 20.83x | 14.19x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.72x |
| EV / EBITDAEnterprise value multiple | 8.63x | 16.70x | 22.38x | 9.37x |
| Price / SalesMarket cap ÷ Revenue | 0.32x | 0.75x | 0.87x | 1.27x |
| Price / BookPrice ÷ Book value/share | 1.35x | 3.31x | 3.19x | — |
| Price / FCFMarket cap ÷ FCF | 3.72x | 20.88x | 11.49x | 12.47x |
Profitability & Efficiency
HCSG leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-5 for AMN. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMN's 1.25x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs AMN's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.0% | +11.5% | +11.8% | — |
| ROA (TTM)Return on assets | -1.4% | +3.9% | +7.3% | +11.3% |
| ROICReturn on invested capital | +1.6% | +9.2% | +9.0% | +19.9% |
| ROCEReturn on capital employed | +2.0% | +9.7% | +7.7% | +27.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.25x | 0.77x | 0.05x | — |
| Net DebtTotal debt minus cash | $769M | $54.0B | -$136M | $49.2B |
| Cash & Equiv.Liquid assets | $34M | $24.4B | $161M | $1.0B |
| Total DebtShort + long-term debt | $803M | $78.4B | $25M | $50.2B |
| Interest CoverageEBIT ÷ Interest expense | -1.70x | 4.71x | 33.02x | 5.37x |
Total Returns (Dividends Reinvested)
HCA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HCA five years ago would be worth $20,974 today (with dividends reinvested), compared to $2,488 for AMN. Over the past 12 months, HCSG leads with a +55.8% total return vs UNH's -3.2%. The 3-year compound annual growth rate (CAGR) favors HCA at 16.3% vs AMN's -37.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +48.7% | +10.6% | +28.6% | -8.6% |
| 1-Year ReturnPast 12 months | +14.6% | -3.2% | +55.8% | +19.7% |
| 3-Year ReturnCumulative with dividends | -75.1% | -19.9% | +48.6% | +57.4% |
| 5-Year ReturnCumulative with dividends | -75.1% | -2.6% | -21.1% | +109.7% |
| 10-Year ReturnCumulative with dividends | -41.5% | +220.6% | -26.8% | +450.5% |
| CAGR (3Y)Annualised 3-year return | -37.1% | -7.1% | +14.1% | +16.3% |
Risk & Volatility
Evenly matched — AMN and HCA each lead in 1 of 2 comparable metrics.
Risk & Volatility
HCA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMN currently trades 94.7% from its 52-week high vs HCA's 77.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.08x | 0.59x | 1.12x | 0.29x |
| 52-Week HighHighest price in past year | $23.74 | $395.52 | $24.39 | $556.52 |
| 52-Week LowLowest price in past year | $14.87 | $234.60 | $12.66 | $330.00 |
| % of 52W HighCurrent price vs 52-week peak | +94.7% | +93.5% | +91.5% | +77.1% |
| RSI (14)Momentum oscillator 0–100 | 57.2 | 75.9 | 61.8 | 30.8 |
| Avg Volume (50D)Average daily shares traded | 849K | 7.9M | 676K | 1000K |
Analyst Outlook
UNH leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AMN as "Buy", UNH as "Buy", HCSG as "Hold", HCA as "Buy". Consensus price targets imply 22.9% upside for HCA (target: $527) vs 0.1% for AMN (target: $23). For income investors, UNH offers the higher dividend yield at 2.35% vs HCA's 0.69%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $22.50 | $385.43 | $24.50 | $527.45 |
| # AnalystsCovering analysts | 17 | 52 | 15 | 46 |
| Dividend YieldAnnual dividend ÷ price | — | +2.4% | — | +0.7% |
| Dividend StreakConsecutive years of raises | — | 25 | 20 | 5 |
| Dividend / ShareAnnual DPS | — | $8.70 | — | $2.94 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +1.7% | +3.9% | +10.5% |
AMN leads in 1 of 6 categories (Valuation Metrics). HCSG leads in 1 (Profitability & Efficiency). 2 tied.
AMN vs UNH vs HCSG vs HCA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AMN or UNH or HCSG or HCA a better buy right now?
For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.
8% revenue growth year-over-year, versus -8. 5% for AMN Healthcare Services, Inc. (AMN). HCA Healthcare, Inc. (HCA) offers the better valuation at 15. 1x trailing P/E (14. 2x forward), making it the more compelling value choice. Analysts rate AMN Healthcare Services, Inc. (AMN) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMN or UNH or HCSG or HCA?
On trailing P/E, HCA Healthcare, Inc.
(HCA) is the cheapest at 15. 1x versus UnitedHealth Group Incorporated at 27. 9x. On forward P/E, AMN Healthcare Services, Inc. is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AMN or UNH or HCSG or HCA?
Over the past 5 years, HCA Healthcare, Inc.
(HCA) delivered a total return of +109. 7%, compared to -75. 1% for AMN Healthcare Services, Inc. (AMN). Over 10 years, the gap is even starker: HCA returned +450. 5% versus AMN's -41. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMN or UNH or HCSG or HCA?
By beta (market sensitivity over 5 years), HCA Healthcare, Inc.
(HCA) is the lower-risk stock at 0. 29β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately 292% more volatile than HCA relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 125% for AMN Healthcare Services, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AMN or UNH or HCSG or HCA?
By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.
8% versus -8. 5% for AMN Healthcare Services, Inc. (AMN). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, UNH leads at 11. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMN or UNH or HCSG or HCA?
HCA Healthcare, Inc.
(HCA) is the more profitable company, earning 9. 0% net margin versus -3. 5% for AMN Healthcare Services, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCA leads at 15. 8% versus 1. 2% for AMN. At the gross margin level — before operating expenses — HCA leads at 41. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMN or UNH or HCSG or HCA more undervalued right now?
On forward earnings alone, AMN Healthcare Services, Inc.
(AMN) trades at 11. 0x forward P/E versus 20. 8x for Healthcare Services Group, Inc. — 9. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HCA: 22. 9% to $527. 45.
08Which pays a better dividend — AMN or UNH or HCSG or HCA?
In this comparison, UNH (2.
4% yield), HCA (0. 7% yield) pay a dividend. AMN, HCSG do not pay a meaningful dividend and should not be held primarily for income.
09Is AMN or UNH or HCSG or HCA better for a retirement portfolio?
For long-horizon retirement investors, HCA Healthcare, Inc.
(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 7% yield, +450. 5% 10Y return). Both have compounded well over 10 years (HCA: +450. 5%, HCSG: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMN and UNH and HCSG and HCA?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AMN is a small-cap quality compounder stock; UNH is a large-cap quality compounder stock; HCSG is a small-cap quality compounder stock; HCA is a mid-cap deep-value stock. UNH, HCA pay a dividend while AMN, HCSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.